Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 7/20 | 1.00 |
| ▸ | DRD2 | P14416 | 7/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 5/20 | 1.00 |
| ▸ | DRD3 | P35462 | 4/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 3/20 | 1.00 |
| ▸ | ADRA2B | P18089 | 3/20 | 1.00 |
| ▸ | ADRA2C | P18825 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | HRH1 | P35367 | 2/20 | 1.00 |
| ▸ | HTR2B | P41595 | 2/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 1/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 1/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Urapidil SCHEMBL29363219 | 1.00 | HTR1A (1.00) | HTR1ADRD2ADRA1ADRD3ADRA2A | |
| Urapidil SCHEMBL30426045 | 0.99 | MAPT (1.00) | HTR1ADRD2ADRA1ADRD3ADRA2A | |
| Urapidil SCHEMBL1321654 | 0.99 | MAPT (1.00) | HTR1ADRD2ADRA1ADRD3ADRA2A | |
| SCHEMBL13532733 | 0.97 | HTR1A (0.94) | HTR1ADRD2ADRA1ADRD3ADRA2A | |
| Urapidil SCHEMBL28768392 | 0.95 | DRD2 (0.91) | HTR1ADRD2ADRA1ADRD3ADRA2A | |
| Urapidil SCHEMBL28768407 | 0.92 | DRD2 (0.84) | HTR1ADRD2ADRA1ADRD3ADRA2A | |
| SCHEMBL7801565 | 0.90 | DRD2 (0.81) | HTR1ADRD2ADRA1ADRD3ADRA2A | |
| SCHEMBL9428413 | 0.85 | ADRA1A (0.74) | HTR1ADRD2ADRA1ADRD3ADRA2A | |
| Hydrochloric Acid SCHEMBL28284797 | 0.84 | MAPT (0.73) | HTR1ADRD2ADRA1ADRD3ADRA2A | |
| SCHEMBL13532743 | 0.82 | HTR1A (0.70) | HTR1ADRD2ADRA1ADRD3ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7876 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122032132-A | Real-time crystal form control method and process control system for urapidil crystallization process | 广东京豪生物制药有限公司 | 2026-05-15 | — | — | CN | claimed |
| EP-4731194-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP Technologies, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4687805-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING ACTIVATED CARBON OR A DERIVATIVE THEREOF | CSP Technologies, Inc. (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260027008-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING ACTIVATED CARBON OR A DERIVATIVE THEREOF | CSP TECHNOLOGIES, INC. | 2026-01-29 | — | — | US | claimed |
| WO-2025264260-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP TECHNOLOGIES, INC. (US) | 2025-12-26 | — | — | WO | claimed |
| US-20250295611-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS INC (US) | 2025-09-25 | — | — | US | claimed |
| US-20250222008-A1 | EYEDROPS CONTAINING AN ALPHA1-BLOCKER FOR INHIBITING MYOPIA PROGRESSION | TSUBOTA LABORATORY, INC. (JP) | 2025-07-10 | — | — | US | claimed |
| EP-4582103-A1 | alpha1 BLOCKER-CONTAINING EYEDROPS FOR INHIBITING MYOPIA PROGRESSION | Tsubota Laboratory, Inc. (JP) | 2025-07-09 | — | — | EP | claimed |
| US-20250213647-A1 | CHEMOKINE RECEPTORS AND ALPHA1 ADRENERGIC RECEPTORS/VASOPRESSIN RECEPTORS 1A HETEROMERS AS DRUG TARGETS FOR DISEASE | UNIVERSITY OF SOUTH FLORIDA | 2025-07-03 | — | — | US | claimed |
| EP-0513058-A1 | USE OF KNOWN URACILES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROTECTION FROM AND TREATMENT OF DISEASES INVOLVING PROLIFERATIVE PROCESSES. | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1992-11-19 | — | — | EP | claimed |
| US-5145851-A | Uracil derivative, side effect reduction | HITACHI CHEMICAL CO., LTD. (JP) | 1992-09-08 | — | — | US | claimed |
| WO-1992014453-A1 | COMPOSITIONS AND METHODS OF TREATMENT OF SYMPATHETICALLY MAINTAINED PAIN | ARC 1, INC. (US) | 1992-09-03 | — | — | WO | claimed |
| WO-1992009273-A1 | RETARDED-ACTION URAPIDIL FORMULATION | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1992-06-11 | — | — | WO | claimed |
| WO-1991011185-A1 | USE OF URAPIDILE AND DERIVATIVES FOR TREATING ARTERIOSCLEROTIC DISEASES | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1991-08-08 | — | — | WO | claimed |
| EP-0416841-A2 | Novel use of 6-[[3-[4-(2- methoxyphenyl)-1-piperazinyl] propyl]amino]-1,3-dimethyluracil for preparing a pharmaceutical for treating urinary obstruction | HITACHI CHEMICAL CO., LTD. (JP) | 1991-03-13 | — | — | EP | claimed |
| US-4988700-A | Antiserotonin agent, aryl or heteroaryl piperazine compounds | TROPONWERKE GMBH & CO. (DE) | 1991-01-29 | — | — | US | claimed |
| EP-0275444-A1 | Pharmaceutical form for urapidil | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1988-07-27 | — | — | EP | claimed |
| US-4747845-A | POLYACRYLATES OR POLYACRYLAMIDE WITH SOLVENT AND HYDROGEN BONDING PLASTICIZER | ENQUAY PHARMACEUTICAL ASSOCIATES (US) | 1988-05-31 | — | — | US | claimed |
| US-4131678-A | LOWER BLOOD PRESSURE | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1978-12-26 | — | — | US | claimed |